Advertisement

Index by author

November 01, 2010; Volume 78,Issue 5

A

  1. Adachi, Tetsuya

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  2. Ahn, Sang-Gun

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  3. Aloisi, Gabriella

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  4. Awaji, Takeo

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

B

  1. Baur, Roland

    1. Monepantel Allosterically Activates DEG-3/DES-2 Channels of the Gastrointestinal Nematode Haemonchus contortus
      Lucien Rufener, Roland Baur, Ronald Kaminsky, Pascal Mäser and Erwin Sigel
      Molecular Pharmacology November 2010, 78 (5) 895-902; DOI: https://doi.org/10.1124/mol.110.066498

  2. Becamel, Carine

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  3. Beinborn, Martin

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  4. Bockaert, Joël

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  5. Bordia, Tanuja

    1. α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease
      Xiomara A. Perez, Tanuja Bordia, J. Michael McIntosh and Maryka Quik
      Molecular Pharmacology November 2010, 78 (5) 971-980; DOI: https://doi.org/10.1124/mol.110.067561

  6. Burkhardt, Sabrina

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  7. Bystricky, Kerstin

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

C

  1. Carrat, Gaelle

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  2. Casado, F. Javier

    1. Different N-Terminal Motifs Determine Plasma Membrane Targeting of the Human Concentrative Nucleoside Transporter 3 in Polarized and Nonpolarized Cells
      Ekaitz Errasti-Murugarren, F. Javier Casado and Marçal Pastor-Anglada
      Molecular Pharmacology November 2010, 78 (5) 795-803; DOI: https://doi.org/10.1124/mol.110.065920

  3. Cavaco, Isa

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  4. Caze-Subra, Stephanie

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  5. Chaudhury, Mousumi

    1. Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
      Sarah R. Walker, Mousumi Chaudhury, Erik A. Nelson and David A. Frank
      Molecular Pharmacology November 2010, 78 (5) 903-908; DOI: https://doi.org/10.1124/mol.110.066316

  6. Cho, Bongjun

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  7. Cho, Kyoung Bin

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  8. Choe, Sung Sik

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  9. Choi, Eun Bok

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  10. Choi, Sung Hee

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  11. Chung, Heekyoung

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  12. Chung, Young Sun

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  13. Ci, Lei

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  14. Crawford, Melissa

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  15. Curini, Massimo

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

D

  1. Dao, Trong Tuan

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  2. de Medina, Philippe

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  3. Dent, Paul

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

  4. Dianov, Grigory L.

    1. Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
      Marcus Eich, Wynand P. Roos, Grigory L. Dianov, Martin Digweed and Bernd Kaina
      Molecular Pharmacology November 2010, 78 (5) 943-951; DOI: https://doi.org/10.1124/mol.110.066076

  5. Digweed, Martin

    1. Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
      Marcus Eich, Wynand P. Roos, Grigory L. Dianov, Martin Digweed and Bernd Kaina
      Molecular Pharmacology November 2010, 78 (5) 943-951; DOI: https://doi.org/10.1124/mol.110.066076

  6. Dollins, Claudia M.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  7. Duan, Lihua

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

E

  1. Eich, Marcus

    1. Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
      Marcus Eich, Wynand P. Roos, Grigory L. Dianov, Martin Digweed and Bernd Kaina
      Molecular Pharmacology November 2010, 78 (5) 943-951; DOI: https://doi.org/10.1124/mol.110.066076

  2. Epifano, Francesco

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  3. Errasti-Murugarren, Ekaitz

    1. Different N-Terminal Motifs Determine Plasma Membrane Targeting of the Human Concentrative Nucleoside Transporter 3 in Polarized and Nonpolarized Cells
      Ekaitz Errasti-Murugarren, F. Javier Casado and Marçal Pastor-Anglada
      Molecular Pharmacology November 2010, 78 (5) 795-803; DOI: https://doi.org/10.1124/mol.110.065920

  4. Eulitt, Patrick

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

F

  1. Fortin, Jean-Philippe

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  2. Frank, David A.

    1. Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
      Sarah R. Walker, Mousumi Chaudhury, Erik A. Nelson and David A. Frank
      Molecular Pharmacology November 2010, 78 (5) 903-908; DOI: https://doi.org/10.1124/mol.110.066316

G

  1. Genovese, Salvatore

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  2. Goldstein, Carmit

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  3. Grant, Steven

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  4. Graves, Lee M.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  5. Griesemer, Désirée

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  6. Griffin, Suzy A.

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

H

  1. Hammond, Scott M.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  2. Han, Hyo-Kyung

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  3. Han, Yang

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  4. Hara, Takafumi

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  5. Hien, Tran Thi

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  6. Hirasawa, Akira

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  7. Hoth, Markus

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  8. Huggins, Gordon S.

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

I

  1. Ingelman-Sundberg, Magnus

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  2. Ishiguro, Masaji

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

J

  1. Javitch, Jonathan A.

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  2. Jeong, Hyun Woo

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

K

  1. Kaina, Bernd

    1. Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
      Marcus Eich, Wynand P. Roos, Grigory L. Dianov, Martin Digweed and Bernd Kaina
      Molecular Pharmacology November 2010, 78 (5) 943-951; DOI: https://doi.org/10.1124/mol.110.066076

  2. Kaminsky, Ronald

    1. Monepantel Allosterically Activates DEG-3/DES-2 Channels of the Gastrointestinal Nematode Haemonchus contortus
      Lucien Rufener, Roland Baur, Ronald Kaminsky, Pascal Mäser and Erwin Sigel
      Molecular Pharmacology November 2010, 78 (5) 895-902; DOI: https://doi.org/10.1124/mol.110.066498

  3. Kang, Keon Wook

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  4. Kim, Hye Ryung

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  5. Kim, Hyung Sik

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  6. Kim, Jae Bum

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  7. Kim, Tae Hyun

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  8. Kim, Tae Hyung

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  9. Kim, Woo Sik

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  10. Kim, Yoon Gyoon

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  11. Kimura, Ikuo

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  12. Kitajima, Shigetaka

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  13. Kopin, Alan S.

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  14. Kwon, Seong-Min

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

L

  1. Labasque, Marilyne

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  2. la Cour, Clotilde Mannoury

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  3. Law, Ping-Yee

    1. Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
      Fatima Macho Sanchez-Simon, Xiao Xiao Zhang, Horace H. Loh, Ping-Yee Law and Raquel E. Rodriguez
      Molecular Pharmacology November 2010, 78 (5) 935-942; DOI: https://doi.org/10.1124/mol.110.066837

  4. Lee, Gha Young

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  5. Lee, Hyun Kyu

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  6. Lee, Joo-Won

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  7. Lee, Jun Hee

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  8. Lingle, Christopher J.

    1. Inhibition of Large-Conductance Ca2+-Activated K+ Channels by Nanomolar Concentrations of Ag+
      Yu Zhou, Xiaoming Xia and Christopher J. Lingle
      Molecular Pharmacology November 2010, 78 (5) 952-960; DOI: https://doi.org/10.1124/mol.110.066407

  9. Loh, Horace H.

    1. Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
      Fatima Macho Sanchez-Simon, Xiao Xiao Zhang, Horace H. Loh, Ping-Yee Law and Raquel E. Rodriguez
      Molecular Pharmacology November 2010, 78 (5) 935-942; DOI: https://doi.org/10.1124/mol.110.066837

  10. Luedtke, Robert R.

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

M

  1. Maggio, Roberto

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  2. Marin, Philippe

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  3. Maruki, Riyo

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  4. Mäser, Pascal

    1. Monepantel Allosterically Activates DEG-3/DES-2 Channels of the Gastrointestinal Nematode Haemonchus contortus
      Lucien Rufener, Roland Baur, Ronald Kaminsky, Pascal Mäser and Erwin Sigel
      Molecular Pharmacology November 2010, 78 (5) 895-902; DOI: https://doi.org/10.1124/mol.110.066498

  5. Mashima, Tetsuo

    1. Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
      Tetsuo Mashima, Sachiko Okabe and Hiroyuki Seimiya
      Molecular Pharmacology November 2010, 78 (5) 846-854; DOI: https://doi.org/10.1124/mol.110.064790

  6. Mazaheri, Mahta

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  7. McIntosh, J. Michael

    1. α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease
      Xiomara A. Perez, Tanuja Bordia, J. Michael McIntosh and Maryka Quik
      Molecular Pharmacology November 2010, 78 (5) 971-980; DOI: https://doi.org/10.1124/mol.110.067561

  8. Meera, Pratap

    1. Alcohol- and Alcohol Antagonist-Sensitive Human GABAA Receptors: Tracking δ Subunit Incorporation into Functional Receptors
      Pratap Meera, Richard W. Olsen, Thomas S. Otis and Martin Wallner
      Molecular Pharmacology November 2010, 78 (5) 918-924; DOI: https://doi.org/10.1124/mol.109.062687

  9. Meffre, Julie

    1. Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants
      Marilyne Labasque, Julie Meffre, Gaelle Carrat, Carine Becamel, Joël Bockaert and Philippe Marin
      Molecular Pharmacology November 2010, 78 (5) 818-826; DOI: https://doi.org/10.1124/mol.110.066035

  10. Millan, Mark J.

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  11. Mitchell, Clint

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

  12. Miyata, Naoki

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  13. Mkrtchian, Souren

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  14. Montefusco, Maria Claudia

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  15. Mwinyi, Jessica

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

N

  1. Nagashima, Takeyuki

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  2. Nana-Sinkam, Serge P.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  3. Nelson, Erik A.

    1. Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
      Sarah R. Walker, Mousumi Chaudhury, Erik A. Nelson and David A. Frank
      Molecular Pharmacology November 2010, 78 (5) 903-908; DOI: https://doi.org/10.1124/mol.110.066316

O

  1. Oh, Won Keun

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

  2. Okabe, Sachiko

    1. Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
      Tetsuo Mashima, Sachiko Okabe and Hiroyuki Seimiya
      Molecular Pharmacology November 2010, 78 (5) 846-854; DOI: https://doi.org/10.1124/mol.110.064790

  3. Olsen, Richard W.

    1. Alcohol- and Alcohol Antagonist-Sensitive Human GABAA Receptors: Tracking δ Subunit Incorporation into Functional Receptors
      Pratap Meera, Richard W. Olsen, Thomas S. Otis and Martin Wallner
      Molecular Pharmacology November 2010, 78 (5) 918-924; DOI: https://doi.org/10.1124/mol.109.062687

  4. Otis, Thomas S.

    1. Alcohol- and Alcohol Antagonist-Sensitive Human GABAA Receptors: Tracking δ Subunit Incorporation into Functional Receptors
      Pratap Meera, Richard W. Olsen, Thomas S. Otis and Martin Wallner
      Molecular Pharmacology November 2010, 78 (5) 918-924; DOI: https://doi.org/10.1124/mol.109.062687

P

  1. Paillasse, Michael R.

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  2. Park, Margaret

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

  3. Park, Seung Bum

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  4. Pastor-Anglada, Marçal

    1. Different N-Terminal Motifs Determine Plasma Membrane Targeting of the Human Concentrative Nucleoside Transporter 3 in Polarized and Nonpolarized Cells
      Ekaitz Errasti-Murugarren, F. Javier Casado and Marçal Pastor-Anglada
      Molecular Pharmacology November 2010, 78 (5) 795-803; DOI: https://doi.org/10.1124/mol.110.065920

  5. Pedersen, Rasmus Steen

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  6. Perez, Xiomara A.

    1. α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease
      Xiomara A. Perez, Tanuja Bordia, J. Michael McIntosh and Maryka Quik
      Molecular Pharmacology November 2010, 78 (5) 971-980; DOI: https://doi.org/10.1124/mol.110.067561

  7. Persson, Anna

    1. Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
      Jessica Mwinyi, Isa Cavaco, Rasmus Steen Pedersen, Anna Persson, Sabrina Burkhardt, Souren Mkrtchian and Magnus Ingelman-Sundberg
      Molecular Pharmacology November 2010, 78 (5) 886-894; DOI: https://doi.org/10.1124/mol.110.065540

  8. Peter, Inga

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  9. Philipp, Stephan E.

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  10. Poirot, Marc

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

Q

  1. Quik, Maryka

    1. α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease
      Xiomara A. Perez, Tanuja Bordia, J. Michael McIntosh and Maryka Quik
      Molecular Pharmacology November 2010, 78 (5) 971-980; DOI: https://doi.org/10.1124/mol.110.067561

R

  1. Raubuch, Michael

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  2. Reis, Steven E.

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  3. Richards, Kristy L.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258

  4. Ro, Seonggu

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  5. Rodriguez, Raquel E.

    1. Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
      Fatima Macho Sanchez-Simon, Xiao Xiao Zhang, Horace H. Loh, Ping-Yee Law and Raquel E. Rodriguez
      Molecular Pharmacology November 2010, 78 (5) 935-942; DOI: https://doi.org/10.1124/mol.110.066837

  6. Roos, Wynand P.

    1. Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
      Marcus Eich, Wynand P. Roos, Grigory L. Dianov, Martin Digweed and Bernd Kaina
      Molecular Pharmacology November 2010, 78 (5) 943-951; DOI: https://doi.org/10.1124/mol.110.066076

  7. Rossi, Mario

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  8. Rössler, Oliver G.

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  9. Rufener, Lucien

    1. Monepantel Allosterically Activates DEG-3/DES-2 Channels of the Gastrointestinal Nematode Haemonchus contortus
      Lucien Rufener, Roland Baur, Ronald Kaminsky, Pascal Mäser and Erwin Sigel
      Molecular Pharmacology November 2010, 78 (5) 895-902; DOI: https://doi.org/10.1124/mol.110.066498

S

  1. Sanchez-Simon, Fatima Macho

    1. Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
      Fatima Macho Sanchez-Simon, Xiao Xiao Zhang, Horace H. Loh, Ping-Yee Law and Raquel E. Rodriguez
      Molecular Pharmacology November 2010, 78 (5) 935-942; DOI: https://doi.org/10.1124/mol.110.066837

  2. Schroeder, Jonathan

    1. The μ-Opioid Receptor Variant N190K Is Unresponsive to Peptide Agonists yet Can be Rescued by Small-Molecule Drugs
      Jean-Philippe Fortin, Lei Ci, Jonathan Schroeder, Carmit Goldstein, Maria Claudia Montefusco, Inga Peter, Steven E. Reis, Gordon S. Huggins, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology November 2010, 78 (5) 837-845; DOI: https://doi.org/10.1124/mol.110.064188

  3. Seimiya, Hiroyuki

    1. Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
      Tetsuo Mashima, Sachiko Okabe and Hiroyuki Seimiya
      Molecular Pharmacology November 2010, 78 (5) 846-854; DOI: https://doi.org/10.1124/mol.110.064790

  4. Shibasaki, Masayuki

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  5. Shigematsu, Nobuharu

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  6. Shimaya, Akiyoshi

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  7. Shimokawa, Teruhiko

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  8. Shin, Dongkyu

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  9. Shin, Hyun Jung

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  10. Sigel, Erwin

    1. Monepantel Allosterically Activates DEG-3/DES-2 Channels of the Gastrointestinal Nematode Haemonchus contortus
      Lucien Rufener, Roland Baur, Ronald Kaminsky, Pascal Mäser and Erwin Sigel
      Molecular Pharmacology November 2010, 78 (5) 895-902; DOI: https://doi.org/10.1124/mol.110.066498

  11. Silvano, Elena

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  12. Silvente-Poirot, Sandrine

    1. Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors
      Philippe de Medina, Salvatore Genovese, Michael R. Paillasse, Mahta Mazaheri, Stephanie Caze-Subra, Kerstin Bystricky, Massimo Curini, Sandrine Silvente-Poirot, Francesco Epifano and Marc Poirot
      Molecular Pharmacology November 2010, 78 (5) 827-836; DOI: https://doi.org/10.1124/mol.110.065250

  13. Spohn, Daniel

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  14. Sun, Qi

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

  15. Suzuki, Takayoshi

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

T

  1. Tanaka, Hirotsugu

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

  2. Thiel, Gerald

    1. Thapsigargin Induces Expression of Activating Transcription Factor 3 in Human Keratinocytes Involving Ca2+ Ions and c-Jun N-Terminal Protein Kinase
      Daniel Spohn, Oliver G. Rössler, Stephan E. Philipp, Michael Raubuch, Shigetaka Kitajima, Désirée Griesemer, Markus Hoth and Gerald Thiel
      Molecular Pharmacology November 2010, 78 (5) 865-876; DOI: https://doi.org/10.1124/mol.110.067637

  3. Tsujimoto, Gozoh

    1. Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
      Qi Sun, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tetsuya Adachi, Takeo Awaji, Masaji Ishiguro, Takayoshi Suzuki, Naoki Miyata and Gozoh Tsujimoto
      Molecular Pharmacology November 2010, 78 (5) 804-810; DOI: https://doi.org/10.1124/mol.110.066324

U

  1. Urano, Yasuharu

    1. Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
      Takeyuki Nagashima, Nobuharu Shigematsu, Riyo Maruki, Yasuharu Urano, Hirotsugu Tanaka, Akiyoshi Shimaya, Teruhiko Shimokawa and Masayuki Shibasaki
      Molecular Pharmacology November 2010, 78 (5) 961-970; DOI: https://doi.org/10.1124/mol.110.065714

W

  1. Walker, Sarah R.

    1. Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
      Sarah R. Walker, Mousumi Chaudhury, Erik A. Nelson and David A. Frank
      Molecular Pharmacology November 2010, 78 (5) 903-908; DOI: https://doi.org/10.1124/mol.110.066316

  2. Wallner, Martin

    1. Alcohol- and Alcohol Antagonist-Sensitive Human GABAA Receptors: Tracking δ Subunit Incorporation into Functional Receptors
      Pratap Meera, Richard W. Olsen, Thomas S. Otis and Martin Wallner
      Molecular Pharmacology November 2010, 78 (5) 918-924; DOI: https://doi.org/10.1124/mol.109.062687

X

  1. Xia, Xiaoming

    1. Inhibition of Large-Conductance Ca2+-Activated K+ Channels by Nanomolar Concentrations of Ag+
      Yu Zhou, Xiaoming Xia and Christopher J. Lingle
      Molecular Pharmacology November 2010, 78 (5) 952-960; DOI: https://doi.org/10.1124/mol.110.066407

Y

  1. Yacoub, Adly

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

  2. Yang, Chen

    1. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
      Clint Mitchell, Margaret Park, Patrick Eulitt, Chen Yang, Adly Yacoub and Paul Dent
      Molecular Pharmacology November 2010, 78 (5) 909-917; DOI: https://doi.org/10.1124/mol.110.067199

  3. Yon, Gyu Hwan

    1. A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
      Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Jun Hee Lee, Eun Bok Choi, Hyun Kyu Lee, Gyu Hwan Yon, Bongjun Cho, Hye Ryung Kim, Sung Hee Choi, Young Sun Chung, Seung Bum Park, Heekyoung Chung, Seonggu Ro and Jae Bum Kim
      Molecular Pharmacology November 2010, 78 (5) 877-885; DOI: https://doi.org/10.1124/mol.110.065748

  4. Yoon, Jung-Hoon

    1. Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
      Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim and Keon Wook Kang
      Molecular Pharmacology November 2010, 78 (5) 855-864; DOI: https://doi.org/10.1124/mol.110.065961

Z

  1. Zazzeroni, Francesca

    1. The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D3 and D2 Receptors
      Elena Silvano, Mark J. Millan, Clotilde Mannoury la Cour, Yang Han, Lihua Duan, Suzy A. Griffin, Robert R. Luedtke, Gabriella Aloisi, Mario Rossi, Francesca Zazzeroni, Jonathan A. Javitch and Roberto Maggio
      Molecular Pharmacology November 2010, 78 (5) 925-934; DOI: https://doi.org/10.1124/mol.110.065755

  2. Zhang, Xiao Xiao

    1. Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
      Fatima Macho Sanchez-Simon, Xiao Xiao Zhang, Horace H. Loh, Ping-Yee Law and Raquel E. Rodriguez
      Molecular Pharmacology November 2010, 78 (5) 935-942; DOI: https://doi.org/10.1124/mol.110.066837

  3. Zhou, Yu

    1. Inhibition of Large-Conductance Ca2+-Activated K+ Channels by Nanomolar Concentrations of Ag+
      Yu Zhou, Xiaoming Xia and Christopher J. Lingle
      Molecular Pharmacology November 2010, 78 (5) 952-960; DOI: https://doi.org/10.1124/mol.110.066407

  4. Zimmerman, Eric I.

    1. Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
      Eric I. Zimmerman, Claudia M. Dollins, Melissa Crawford, Steven Grant, Serge P. Nana-Sinkam, Kristy L. Richards, Scott M. Hammond and Lee M. Graves
      Molecular Pharmacology November 2010, 78 (5) 811-817; DOI: https://doi.org/10.1124/mol.110.066258
Back to top

In this issue

Advertisement